Cited by 430Complement system in diseasesBiomarkers in Disease MechanismsCoagulation, Bradykinin, Polyphosphates, and Angioedema

The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.

Complement and Its Receptors: New Insights into Human Disease

Open access

Holers, V. Michael·2014·Annual Review of Immunology

DOI 10.1146/annurev-immunol-032713-120154

Open this paper in CoChat — free account Open PDF

Abstract

Although new activation and regulatory mechanisms are still being identified, the basic architecture of the complement system has been known for decades. Two major roles of complement are to control certain bacterial infections and to promote clearance of apoptotic cells. In addition, although inappropriate complement activation has long been proposed to cause tissue damage in human inflammatory and autoimmune diseases, whether this is indeed true has been uncertain. However, recent studies in humans, especially those using newly available biological therapeutics, have now clearly demonstrated the pathophysiologic importance of the complement system in several rare diseases. Beyond these conditions, recent genetic studies have strongly supported an injurious role for complement in a wide array of human inflammatory, degenerative, and autoimmune diseases. This review includes an overview of complement activation, regulatory, and effector mechanisms. It then focuses on new understandings gained from genetic studies, ex vivo analyses, therapeutic trials, and animal models as well as on new research opportunities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev-immunol-032713-120154

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 3×
“Additionally, the recently recognized roles of complement in homeostasis point to several nontraditional functions that bridge immunity and developmental biology (12).”
BackgroundInfluential
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,653
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
The Instructive Role of Innate Immunity in the Acquired Immune Response
Fearon, D. T., & Locksley, R. M. (1996) · Science · doi:10.1126/science.272.5258.50 · Cited by 1,711
C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
Dempsey, P. W., Allison, M. E. D., Akkaraju, S., Goodnow, C. C., & Fearon, D. T. (1996) · Science · doi:10.1126/science.271.5247.348 · Cited by 1,197
Generation of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M. S., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 976
MOLECULAR ORGANIZATION AND FUNCTION OF THE COMPLEMENT SYSTEM
Müller‐Eberhard, H. J. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.001541 · Cited by 856
Discovery and Development of the Complement Inhibitor Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778 · cited 2×
“On red blood cells, the absence of DAF allows alternative pathway–initiated complement activation by C3 and C5 convertases; the absence of CD59 allows activated C5 to proceed to form the MAC, resulting in intravascular hemolysis (102, 103).”
Background
Modulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C. J., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 770
Molecular Intercommunication between the Complement and Coagulation Systems
Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Brückner, U. B., Nilsson, B., Gebhard, F. T., Lambris, J. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903678 · Cited by 719

Show all 152 references

Research works printed but not linked: 6

Holers VM, 1989, Year Immunol., 4, 231
Song JJ, 2011, J. Clin. Investig., 121, 3517
Rose KL, 2008, J. Clin. Investig., 118, 608
Calero I, 2010, Discov. Med., 10, 416
He S, 2009, J. Clin. Investig., 119, 2304
Thurman JM, J. Clin. Investig., 123, 2103

Sorted by citations

Items 301–400 of 430

Pathophysiological Protein Corona Governs the Biological Fate of Nanoparticles
Han, W., Shi, X., Niu, Y., Guo, J., Wang, X., Mu, Q., Jiang, S., & Yang, H. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c23016 · Cited by 4
C5a stimulation induces caspase-1 activation and mature IL-1β production in human peripheral blood mononuclear cells
Fujita, Y., Matsumoto, H., Inada, K., Onizawa, M., Saito, K., Sumichika, Y., Yoshida, S., Temmoku, J., Matsuoka, N., Asano, T., et al. (2023) · Immunological Medicine · doi:10.1080/25785826.2023.2292665 · Cited by 4
Chronic treatment with the antipsychotic lurasidone modulates the neuroinflammatory changes associated with the vulnerability to chronic mild stress exposure in female rats
Begni, V., Silipo, D. M., Bottanelli, C., Papp, M., Cattaneo, A., & Riva, M. A. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.001 · Cited by 4
Characteristics and Outcomes of Renal Transplant Recipients With Hemolytic Uremic Syndrome in the United States
Tanrıöver, B., Lakhia, R., Shen, Y.-M. P., Sandıkçı, B., Saxena, R., MacConmara, M. P., Soyombo, A. A., Rajora, N., & Hardy, M. A. (2015) · Transplantation Direct · doi:10.1097/txd.0000000000000555 · Cited by 4
Déficits immunitaires héréditaires de l’immunité innée et infections
Duchamp, M., Miot, C., Bustamante, J. C., & Pïcard, C. (2016) · Archives de Pédiatrie · doi:10.1016/j.arcped.2016.04.020 · Cited by 4
Nanotoxicity of Lipid-Based Nanomedicines
Morilla, M. J., & Romero, E. L. (2018) · Springer eBooks · doi:10.1007/978-3-030-05144-0_8 · Cited by 4
Prognostic Significance of Serum Complement Component 3 in Chronic Rhinosinusitis with Nasal Polyps
Wang, F., Yang, Y., You, Q., & Chen, H. (2020) · ORL · doi:10.1159/000504195 · Cited by 4
Identification of diagnostic signatures for ischemic stroke by machine learning algorithm
Li, Q., Tian, Y., Niu, J., Guo, E., Lu, Y., Dang, C., Feng, L., Li, L., & Wang, L. (2024) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2024.107564 · Cited by 4
A new drug for rare diseases: pozelimab for CHAPLE disease
Bélot, A., Benezech, S., & Tusseau, M. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02652-1 · Cited by 4
Is the Complement System Dysregulated in Preeclampsia Comorbid with HIV Infection?
Govender, S., David, M., & Naicker, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116232 · Cited by 4
A modern view on the complement system
Сергеевич, Ш. С., Filippova, A. E., Butilin, A. A., & Ataullakhanov, F. I. (2019) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/1726-1708-2019-18-3-130-144 · Cited by 4
Complement-Targeted Therapies in Lupus
Gilkeson, G. S. (2015) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-014-0009-9 · Cited by 4
Effectiveness of C5a aptamers in a TNBS‑induced colitis mouse model
Li, Z., Wang, X., Chen, M., Wang, Y., Sun, R., Qu, H., Sun, Y., Gao, W., Li, B., Dong, X., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5277 · Cited by 4
Interaction with complement proteins and dendritic cells implicates LCCL domain-containing proteins (CCps) of malaria parasites in immunomodulation
Sijwali, P. S. (2018) · Biochemical Journal · doi:10.1042/bcj20180494 · Cited by 4
Vasculitis-Associated Auto-antibodies and Complement Levels in patients with COVID-19 InfectionPreprint
Mobini, M., Ghasemian, R., Larijani, L. V., Mataji, M., & Maleki, I. (2020) · doi:10.21203/rs.3.rs-30488/v1 · Cited by 4
Splenic red pulp macrophages eliminate the liver-resistant Streptococcus pneumoniae during bloodstream infectionPreprint
Huang, Y., Zhao, Z., Li, K., Huang, X., Tian, X., Meng, J., Zhou, H., Wu, J., Dai, Q., Zhang, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.26.591417 · Cited by 4
Complement and local ocular inflammatory response: Chronic immune factors in myopia
Zhang, M., Mo, Y., Gao, J., Qu, W., Chen, A., Wu, S., & Zhang, Y. (2025) · Science Progress · doi:10.1177/00368504251383046 · Cited by 4
Low serum complements in idiopathic inflammatory myositis: clinical features and impact on the prognosis
Nomura, S., Shimojima, Y., Kishida, D., Ichikawa, T., Matsushima, A., & Sekijima, Y. (2024) · Immunological Medicine · doi:10.1080/25785826.2024.2370083 · Cited by 3
Complement in Control of Infectious Agents
Frank, M. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00103-1 · Cited by 3
A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureus
Sage, M. A. G., Cranmer, K. D., Semeraro, M. L., Ma, S., Galkina, E., Tran, T. H. Y., Wycoff, K. L., & Sharp, J. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265774 · Cited by 3
Role of interleukin 6 polymorphism and inflammatory markers in outcome of pediatric Covid- 19 patients
AbdelAziz, R. A., Abd-Allah, S. T., Moness, H., Anwar, A. M., & Mohamed, Z. H. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-05071-9 · Cited by 3
Genetik der Alzheimer-Krankheit
Bajaj, T., Ramı́rez, A., & Wagner-Thelen, H. (2018) · Medizinische Genetik · doi:10.1007/s11825-018-0193-3 · Cited by 3
Exploring Relevant mRNAs and miRNAs in Injured Urethral Tissues of Rats with High-Throughput Sequencing
Lin, H., Guo, S., Li, S., Shen, J., He, J., Zheng, Y., & Gao, Z. (2022) · Genes · doi:10.3390/genes13050824 · Cited by 3
Sertoli Cell-Based Gene Therapy?
Cupp, A. S. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.121996 · Cited by 3
Membranoproliferative and C3-Mediated GN in Children
Licht, C. P. B., Riedl, M., Pickering, M. C., & Braun, M. (2015) · Springer eBooks · doi:10.1007/978-3-642-27843-3_29-1 · Cited by 3
Influence of mannan-binding lectin and MAp44 on outcome in comatose survivors of out-of-hospital cardiac arrest
Bro‐Jeppesen, J., Kjærgaard, J., Thiel, S., Jensenius, J. C., Bjerre, M., Wanscher, M. J., Christensen, J. V., & Hassager, C. (2016) · Resuscitation · doi:10.1016/j.resuscitation.2016.01.007 · Cited by 3
Immune Responses to Viral Infection
Streeck, H., Suscovich, T. J., & Alter, G. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch16 · Cited by 3
Immune Complex Diseases
Warren, J. S., & Ward, P. A. (2017) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0002164.pub3 · Cited by 3
Complement Receptors
Verschoor, A., Kemper, C., & Köhl, J. (2017) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0000512.pub3 · Cited by 3
Phagocytosis: Enhancement
Peiser, L. (2016) · Wiley eBooks · doi:10.1002/9780470015902.a0001214.pub3 · Cited by 3
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study
Sandhu, A., Shen, T., Herrero, P. M., Yuan, C., Qureshi, S., Jiang, X., Shen, Y., Gasteyger, C., & Dai, Y. (2025) · Clinical and Translational Science · doi:10.1111/cts.70190 · Cited by 2
Immunostimulating and Anticancer Activities of the Pectic Polysaccharide from Panax ginseng Leaves Treated with High Pressure/Enzyme Process
Son, S., Hong, K. R., & Shin, K. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040257 · Cited by 2
The evolving landscape of complement therapeutics in rheumatology
Holers, V. M. (2026) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2026.02.020 · Cited by 2
Self-citation
Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus
Assem, N. M., Mohammed, A. I., Barry, H. M. A., Sayed, I. E. T. E., & Elmadbouh, I. S. (2022) · Egyptian Liver Journal · doi:10.1186/s43066-022-00231-x · Cited by 2
Plasma complement proteins as biomarkers and therapeutic targets in chronic kidney disease: a Mendelian randomization analysis
Xu, Y., Song, Z.-Q., Chen, M., Fang, Y.-L., & Zhang, H. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2525473 · Cited by 4
Potential biochemical markers of chronic bronchitis
Kurtukov, E. A., & Ragino, Y. I. (2021) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2021-2-148-159 · Cited by 2
Osteoarthritis and the Immune System
Goldring, M. B., Dayer, J., & Goldring, S. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00014-1 · Cited by 2
Biomaterials for Engineering Immune Responses
Jhunjhunwala, S. (2018) · Journal of the Indian Institute of Science · doi:10.1007/s41745-018-0063-7 · Cited by 2
Plasma samples from mouse strains and humans demonstrate different susceptibilities to complement activation
Dobrovolskaia, M. A., Neun, B. W., Szénási, G., & Szebeni, J. (2018) · Precision Nanomedicine · doi:10.33218/prnano1(3).181029.2 · Cited by 2
Respuesta inmune innata y sus implicaciones fisiopatológicas
Martín, D. D., Cantera, M., López-Suárez, A., & Soto, M. Á. D. M. (2017) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.12.009 · Cited by 3
Immunity: Humoral and Cellular
Harrison, L. C. (2016) · Wiley eBooks · doi:10.1002/9780470015902.a0001236.pub3 · Cited by 2
Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defencePreprint
McCulloch, L. J., Allan, S. M., Smith, C. J., & McColl, B. W. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/587881 · Cited by 2
Reply to “Investigating the Immunopathogenic Mechanisms Underlying MOGAD ”
Keller, C. W., Lopez, J. A., Wendel, E., Ramanathan, S., Groß, C. C., Klotz, L., Reindl, M., Dale, R. C., Wiendl, H., Rostasy, K. M., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26278 · Cited by 2
Our Compliments to the Authors: Decay Accelerating Factor and the Complement System in Pulmonary Fibrosis
Hamanaka, R. B., & Mutlu, G. M. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0268ed · Cited by 2
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular SubtypingPreprint
Wang, K., Nie, Y., Maguire, C. P., Syphurs, C., Sheen, H., Karoly, M., Lapp, L., Gygi, J. P., Jayavelu, N. D., Patel, R. K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.22.624784 · Cited by 2
Platelet Transfusion
Meledeo, M. A., Thomas, K. A., Bynum, J. A., Reddoch‐Cardenas, K. M., Getz, T. M., Pidcoke, H. F., Spinella, P. C., & Cap, A. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-53606-0_23 · Cited by 1
Assessment of biomarkers indicating activation of the complement system in pregnant women with fetal growth restriction
Ersan, F., Bakırcı, I. T., Şener, G., Çallıoğlu, N., Atalay, S., & Tuna, G. (2024) · Journal of Medicine and Palliative Care · doi:10.47582/jompac.1466260 · Cited by 1
Complement or insult: the emerging link between complement cascade deficiencies and pathology of myeloid malignancies
Oakes, A., Liu, Y., & Dubielecka, P. M. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae130 · Cited by 1
Plant derived bioactive compounds for the treatment of neurodegeneration and neuroimmune disorders associated with the complement system
Narayanaperumal, J., & Gopal, G. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00170 · Cited by 1
MAp44: Emerging Insights into Its Role in Disease Pathogenesis and Association with Various Diseases
Pamei, Y. G., Swekcha, Sharma, N., & Toor, D. (2025) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2025057896 · Cited by 1
Complement in tuberculosis infection and disease, a battle of two ancients.
Dijkman, K., Joosten, S., & Trouw, L. (2026) · Immunobiology · doi:10.1016/j.imbio.2026.153183
Clearance of Early Complement Protein From CSF After Aneurysmal Subarachnoid Hemorrhage and Influence on Neurologic Outcome
Geraghty, J. R., Katz, E. A., Butler, M. P., & Testai, F. D. (2026) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200582 · Cited by 1
An in vitro model mimicking the complement system to favor directed phagocytosis of unwanted cells
Bartsch, I. M., Perelmuter, K., Bollati‐Fogolín, M., Bartsch‐Jiménez, A., Guzmán, F., & Marshall, S. H. (2020) · Electronic Journal of Biotechnology · doi:10.1016/j.ejbt.2020.09.010 · Cited by 1
Complement System
Ward, P. A., & Kemper, C. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch30 · Cited by 1
El sistema del complemento y su papel en las enfermedades cutaneas
Luca, D. A. D., & Torre, A. C. (2021) · Dermatología Argentina · doi:10.47196/da.v27i4.2237 · Cited by 1
Complement and Complement Disorders
Atkinson, J. P., Liszewski, M. K., Java, A., & Kulkarni, H. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00040-x · Cited by 1
Genetic mapping of complement system proteins for islet autoimmunity in children with high risk of T1D
Hu, X., Webb‐Robertson, B., Parikh, H. M., Nakayasu, E. S., Önengüt-Gümüşcü, S., Chen, W., Frazer‐Abel, A. A., Metz, T., Rich, S. S., Rewers, M., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08739-9 · Cited by 2
Innate and Adaptive Systems of Immunity
Delves, P. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00005-8 · Cited by 1
Paroxysmal nocturnal hemoglobinuria: new concepts in pathophysiology and treatment
Weitz, I. C. (2015) · Orphan Drugs Research and Reviews · doi:10.2147/odrr.s73641 · Cited by 1
Does Complement Have a Role in the Pathogenesis of Alopecia Areata?
Juhász, M. L. W., & Mesinkovska, N. A. (2018) · Skin Appendage Disorders · doi:10.1159/000487448 · Cited by 1
Lupus activity in a patient with end-stage renal disease: A case report
Gómez, N. G., Franco, C. J. V., Pineda, F. L., & Palacio, J. C. (2021) · Revista Colombiana de Reumatología (English Edition) · doi:10.1016/j.rcreue.2020.01.008 · Cited by 1
Fungal Immunology: Mechanisms of Host Innate Immune Recognition and Evasion by Pathogenic Fungi
Anjum, F. R., Anam, S., Luqman, M., AL-surhanee, A. A., Shater, A. F., Usmani, M. W., Rahman, S. U., Sajid, M. S., Rizvi, F., & Shakir, M. Z. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101415 · Cited by 1
The Assessment of Complement Proteins in Patients With Severe COVID-19
Ghazavi, A., Mosayebi, G., Keshavarzian, N., Rabiemajd, S., & Ganji, A. (2021) · International journal of basic science in medicine · doi:10.34172/ijbsm.2021.27 · Cited by 1
Complement: The Alternative Pathway
Zipfel, P. F., & Skerka, C. (2015) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0000509.pub3 · Cited by 1
Multivalent Lectin–Glycan Interactions in the Immune System
Monteiro, J. T., & Lepenies, B. (2017) · doi:10.1002/9781119143505.ch13 · Cited by 1
Complement facilitates developmental microglial pruning of astrocyte and vascular networksPreprint
Gnanaguru, G., Tabor, S. J., Bonilla, G. M., Sadreyev, R. I., Yuda, K., Köhl, J., & Connor, K. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.12.476001 · Cited by 1
Genular: An Integrated Platform for Defining Cellular Identity and Function through Single-Cell Gene Expression and Multi-Domain Biological DataPreprint
Tomic, I., Hao, S. P., & Tomić, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.23.619445 · Cited by 1
Implicações da variante da cadeia CD11b (rs1143679) do CR3 para a liberação da mieloperoxidase de neutrófilos humanos
Júnior, J. R. L. (2015) · doi:10.11606/d.60.2015.tde-15052015-094944
Impact of IL-7 signaling on adoptive T cell therapy
Deiser, K. (2016) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/17419
Inflammatory Products of the Complement Pathway
Friec, G. L., & Kemper, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.02016-6
Clinical Significance of Complement Abnormalities
Kirschfink, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.18024-5
Chikungunya Virus Pathogenesis
Hawman, D. W., & Morrison, T. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-42958-8_10
Signaling and Effector Molecules in Immunity
Milone, M. C. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47377-2_3
O papel do receptor C5a em um modelo murino de doença dos Legionários
Stifanic, R. (2017) · doi:10.11606/d.17.2017.tde-05012017-124528
Microangiopatía trombótica e injuria renal aguda en el primer trimestre de embarazo
González-Hoyos, I., Lombi, F., Forrester, M., Pomeranz, V., Iriarte, R., Rengel, T., Paulero, M., Gianserra, R., González, I., Iotti, A., et al. (2018) · Fronteras en Medicina · doi:10.31954/rfem/201803/0154-0157
Perfil de variação no número de cópias do DNA e regiões de perda de heterozigose na susceptibilidade ao lúpus eritematoso sistêmico
Barbosa, F. B. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-10042018-155016
Assessment of the visual thalamic circuitry in hallucinations in dementia with Lewy bodies
Erskine, D. (2017)
C1q: A Molecular Bridge to Innate and Adaptive Immunity
Ghebrehiwet, & Kishore, U. (2020) · Frontiers research topics · doi:10.3389/978-2-88963-706-5
Actividad lúpica en paciente con enfermedad renal terminal: reporte de caso
Gómez, N. G., Franco, C. J. V., Pineda, F. L., & Palacio, J. C. (2020) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2020.01.006
Scientific memory from the early nineties; a common project with professors late János Gergely and Anna Erdei
Falus, A., & Bajtay, Z. (2021) · Biologia Futura · doi:10.1007/s42977-020-00056-y
Acquired Pure Red Cell Aplastic in one of the Monozygotic Twins with Common Variable ImmunodeficiencyPreprint
Shen, L. J., Gao, X., Hou, J. Q., & Wan, Y. K. (2021) · Research Square · doi:10.21203/rs.3.rs-740295/v1
Pharmacokinetics, pharmacodynamics and safety evaluation of 5,5’-methylenebis(2-acetoxybenzoic acid) in dogs following intravenous administration
Goggs, R. A. N., Kannampuzha‐Francis, J., Campbell, C. J., Moreau, J., & Behling‐Kelly, E. L. (2021) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2021.110339
Experimentally Induced Anti-Myeloperoxidase Vasculitis Is Not Attenuated in Factor B or VISTA Deficient Mice
Flórez‐Barrós, F., Freeley, S. J., Tham, E. L., & Robson, M. G. (2021) · Glomerular Diseases · doi:10.1159/000521233
Estudos de fatores regulados por CovR e VicRK envolvidos na susceptibilidade à opsonização pelo sistema complemento e na virulência sistêmica de "Streptococcus mutans"
Alves, L. A. (2017) · doi:10.47749/t/unicamp.2017.991263
Complement System
Popescu, N. I., & Lupu, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-53606-0_12
Complement Factor H (CFH)
Lamas-Basulto, E., Dersch, A. M., & Cortés, C. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101784-1
Angeborene und adaptive Immunsysteme
(2017) · Wiley-VCH eBooks · doi:10.1002/9783527698448.ch24
Proteolytic Cascades
Lupu, F., Popescu, N. I., & Coggeshall, K. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.02020-8
Complement Assays
Grumach, A. S., & Kirschfink, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00180-4
Surfactant protein A /D-CD14 is Associated with Phagocytosis of Nanomaterials and Cytokine Production by Alveolar MacrophagesPreprint
Xu, J., Wang, Q., Wang, Q., Zhao, Z., Fan, J., Qin, L., Alexander, D. B., Tsuda, H., & Zhao, D. (2021) · Research Square · doi:10.21203/rs.3.rs-222608/v1
Complement Factor H (CFH)
Lamas-Basulto, E., Dersch, A. M., & Cortés, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101784
Low serum complement level is associated with higher mortality in tuberculous meningitis: a retrospective cohort study
Im, H., Kim, T., Na, S., Song, I., Kim, S. H., Oh, Y., Oh, J., & Kim, W. (2022) · encephalitis · doi:10.47936/encephalitis.2022.00059
Papel do componente C5 do sistema complemento no controle da infecção por Trypanosoma cruzi
Salgado, R. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2019.tde-14122022-100503
Association of Proliferative Diabetic Retinopathy in the Elderly with the Blood Complement System
Фабрикантов, О. Л., Агарков, Н. М., Лев, И. В., Станиславовна, Г. Т., & Иванович, Н. С. (2023) · Ophthalmology in Russia · doi:10.18008/1816-5095-2022-4-829-834
Humoral immunity and thrombosis in COVID-19
Lasagni, G., Borghi, M. O., Cugno, M., & Meroni, P. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00037-2
Nasal Defensive Proteins: Distribution and a Biological Function
Kawauchi, H. (2023) · Springer eBooks · doi:10.1007/978-3-031-12386-3_29
Development of myeloid cell-based immune profiling on microarrays
Szittner, Z. (2017) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2016.056
Pegcetacoplan in the treatment of geographic atrophy
Kumar, M., & Singh, R. P. (2023) · Immunotherapy · doi:10.2217/imt-2022-0263
Avanços recentes na compreensão da patogênese da Artrite Reumatoide: insights e implicações terapêuticas
Silva, B. F., Junqueira, J. R., Pinheiro, G. M. B., Eisenberger, A. L. C., Hanna, A. C. L., Autran, G. N. V. S., Wu, M. F., Reis, K. C. P. D., Coelho, R. D. F., Garcia, V. S., et al. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n4-037
ԿՈՄՊԼԵՄԵՆՏԻ ՀԱՄԱԿԱՐԳԻ ԴԵՐԸ ԱԿՆԱՅԻՆ ՊԱԹՈԼՈԳԻԱՆԵՐԻ ԷԹԻՈՊԱԹՈԳԵՆԵԶՈՒՄ (ՏԵՍՈՒԹՅԱՆ ՎԵՐԼՈՒԾՈՒԹՅՈՒՆ)
Kambulyan, L. (2023) · MEDICINE SCIENCE AND EDUCATION · doi:10.56936/18291775-2023.36-62

Authors: Holers, V. M.
Affiliations: University of Colorado Anschutz (US)
Corresponding author: Holers, V. Michael
ORCID: Holers, V. Michael
Venue: Annual Review of Immunology
Publisher: Annual Reviews
Published: 2014-03-21
Volume: 32
Issue: 1
Pages: 433-459
ISSN: 0732-0582 (ISSN-L)
1545-3278
DOI: 10.1146/annurev-immunol-032713-120154
OpenAlex: W2163243965
Cited by: 430
References: 152
Citations by year: 2026: 21 · 2025: 25 · 2024: 33 · 2023: 27 · 2022: 39 · 2021: 48 · 2020: 46 · 2019: 42 · 2018: 34 · 2017: 40 · 2016: 36 · 2015: 27 · 2014: 10
FWCI: 3.68
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Annual Review of Immunology (publishedVersion)
PubMed (publishedVersion)
Funders: Lupus Research Alliance
National Institutes of Health
National Institute of Allergy and Infectious Diseases (R21AI105717)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR051749)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Keywords: complement system, complement receptors, complement activation, complement regulation, efferocytosis, bacterial infection, inflammatory diseases, autoimmune disease, degenerative diseases, rare diseases, genetic research, complement therapeutics, tissue damage
MeSH terms: Animals, Carrier Proteins, Complement System Proteins, Complement Activation, Disease Models, Animal, Disease Susceptibility, Humans, Protein Binding, Receptors, Complement, Signal Transduction, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Complement and Its Receptors: New Insights into Human Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks